The latest price target for MedMen Enterprises Inc (OTC:MMNFF) was reported by Cantor Fitzgerald on November 3, 2021. The analyst firm set a price target for $0.25 expecting MMNFF to fall to within 12 months (a possible NaN% downside). 0 analyst firms have reported ratings in the last year.

The latest analyst rating for MedMen Enterprises Inc (OTC:MMNFF) was provided by Cantor Fitzgerald, and MedMen Enterprises Inc maintained their neutral rating.

The last upgrade for MedMen Enterprises Inc happened on August 18, 2021 when Cantor Fitzgerald raised their price target to $0.3. Cantor Fitzgerald previously had an underweight for MedMen Enterprises Inc.

There is no last downgrade for MedMen Enterprises Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of MedMen Enterprises Inc, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for MedMen Enterprises Inc was filed on November 3, 2021 so you should expect the next rating to be made available sometime around November 3, 2022.

While ratings are subjective and will change, the latest MedMen Enterprises Inc (MMNFF) rating was a maintained with a price target of $0.30 to $0.25. The current price MedMen Enterprises Inc (MMNFF) is trading at is $undefined, which is out of the analyst’s predicted range.